Unclear Diagnoses in Patients with Metastatic Disease

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
September 20, 2013

Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products

July 17, 2018

How Molecular Biomarkers Have Impacted Cancer Treatment

Drs Geoffrey Oxnard and Lauren Ritterhouse discuss the challenges and opportunities of precision medicine and molecular biomarkers in their clinical practice from an oncologist’s and a pathologist’s perspective.